Improving cancer treatment through rapid, cost-effective drug development

 

 

Oxilio is a pioneering pharmaceutical drug development company working to identify, repurpose and commercialise existing drugs to address unmet needs in cancer therapy.

 

We find new uses for old drugs, a proven approach that involves less time, cost and risk to bring a drug to the marketplace.